Infirmary Cancer Care — Mobile, Alabama

Infirmary Cancer Care is a clinical research site located in Mobile, Alabama, United States 36607.

Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

Infirmary Cancer Care has participated in 12 clinical trials with 8 currently active.

Therapeutic areas: Follicular Lymphoma, Brain Metastases From Non-small Cell Lung Cancer (NSCLC), Carcinoma, Non-Small-Cell Lung.

Sponsors: Celgene, NovoCure GmbH, Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Infirmary Cancer Care?

Infirmary Cancer Care has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Infirmary Cancer Care conducted?

Infirmary Cancer Care has 12 clinical trials on record, with 8 currently active. Their work covers Follicular Lymphoma, Brain Metastases From Non-small Cell Lung Cancer (NSCLC), Carcinoma, Non-Small-Cell Lung.

Is Infirmary Cancer Care accredited by Crixeo Health?

Yes — Infirmary Cancer Care holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Infirmary Cancer Care?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.